会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • COMPOSITIONS AND METHODS COMPRISING ZINGIBER SPECIES
    • 包含ZINGIBER种类的组合物和方法
    • WO2008070783A3
    • 2008-09-12
    • PCT/US2007086653
    • 2007-12-06
    • HERBALSCIENCE SINGAPORE PTE LTDLI DANSYPERT GEORGE WGOW ROBERT T
    • LI DANSYPERT GEORGE WGOW ROBERT T
    • A61K36/906
    • A61K36/9068A61K31/12A61K31/715
    • An aspect of the present invention relates to compositions comprising a gingerol, for example, compositions comprising gingerol in an amount greater than about 2% by weight. In some aspects of the invention, the composition comprises 6-gingerol, 8-gingerol, 10- gingerol, 6-shagaol, or combinations thereof. Another aspect of the invention relates to a method for extracting a ginger species comprising, sequentially extracting a ginger species plant material to yield an essential oil fraction, a gingerol fraction, a phenolic fraction, and a polysaccharide fraction, wherein the essential oil and gingerol fractions are derived by extracting plant feedstock material by supercritical carbon dioxide extraction, the phenolic fraction is extracted from the plant feedstock material or from the remainder of the essential oil and gingerol extractions by hydroalcoholic extraction, and the polysaccharide fraction is derived by water extraction of the remainder of the phenolic extraction.
    • 本发明的一个方面涉及包含姜酚的组合物,例如包含量大于约2重量%的姜醇的组合物。 在本发明的一些方面,组合物包含6-姜酚,8-姜酚,10-姜醇,6-三聚醇或其组合。 本发明的另一方面涉及一种用于提取姜物种的方法,其包括依次提取姜物种植物材料以产生精油​​馏分,姜酚馏分,酚类馏分和多糖馏分,其中精油和姜醇馏分 是通过超临界二氧化碳萃取提取植物原料材料而得到的,酚类级分是通过水醇提取从植物原料或其余精油和姜酚提取物中提取的,并且通过水提取其余部分 的酚萃取。
    • 9. 发明申请
    • METHODS AND COMPOSITIONS COMPRISING ILEX
    • 包含ILEX的方法和组合物
    • WO2005041997A8
    • 2006-08-10
    • PCT/US2004035098
    • 2004-10-25
    • HERBALSCIENCE LLCGOW ROBERT TSYPERT GEORGE WPIERCE JOHN WMARENTIS RODGE MLI DANYAN XUN
    • GOW ROBERT TSYPERT GEORGE WPIERCE JOHN WMARENTIS RODGE MLI DANYAN XUN
    • A23F3/00A61K31/522A61K36/00A61K36/185
    • A61K36/185
    • The present invention comprises methods for making compositions derived from Ilex species, particularly Ilex paraguariensis, having lowered caffeine and tannin concentrations, compositions made by such methods, oral delivery formulations, and methods of use of such compositions. In particular, the present invention comprises methods for making maté compositions that have a predetermined characeteristic, such as a lowered amount of caffeine, elevated amounts of caffeoyls, and/or lowered amounts of tannin compounds compared to the native maté plant materials. Further, the invention comprises methods of additional processing steps tp produce compositions having a predetermined alkaloid ratio or profiles to meet particular considerations for final products. The compositions of the present invention may be processed for specific uses such as tablets or other oral delivery vehicles. These compositions may be used in methods for treatment of physiological and medical conditions.
    • 本发明包括用于制备衍生自具有降低的咖啡因和单宁浓度的Ilex种,特别是白僵菌的组合物的组合物的方法,通过这些方法制备的组合物,口服递送制剂和使用该组合物的方法。 特别地,本发明包括与天然植物材料相比制备具有预定特征的maté组合物的方法,例如降低量的咖啡因,升高的咖啡因量和/或降低量的单宁化合物。 此外,本发明包括另外的加工步骤的方法,tp产生具有预定生物碱比例或轮廓的组合物以满足最终产品的特定考虑。 本发明的组合物可以用于特定用途如片剂或其它口服递送载体。 这些组合物可用于治疗生理和医学状况的方法。
    • 10. 发明申请
    • EXTRACTS OF CRANBERRY AND METHODS OF USING THEREOF
    • 藤蔓提取物及其使用方法
    • WO2009149288A3
    • 2010-03-25
    • PCT/US2009046302
    • 2009-06-04
    • HERBALSCIENCE GROUP LLCALBERTE RANDALL SROSCHEK WILLIAM PLI DAN
    • ALBERTE RANDALL SROSCHEK WILLIAM PLI DAN
    • A61K36/45A23L1/30A61K9/06A61K36/54A61P13/00A61P31/04
    • A61K9/0034A23L33/105A23V2002/00A61K9/0014A61K9/7023A23V2250/21
    • The present disclosure relates in part to extracts of cranberry (Vaccinium macrocarpon) comprising an enriched amount of certain compounds having anti-infective activity, e.g. antibacterial and/or antifungal activity, e.g. activity against C. albicans. Another aspect of the disclosure relates to combined cranberry and cinnamon extracts. In certain embodiments, these combined extracts have been optimized to control urinary tract infections caused by E. coli, S. aureus and C. albicans. Certain embodiments of the extract are enriched in bioactive compounds that have been shown to inhibit C. albicans adhesion and/or bio film formation and its growth in vitro. In another aspect of the disclosure, the extracts are enriched in bioactives derived from cranberry and cinnamon that have been shown to inhibit the attachment and the growth of common urinary tract pathogens like E. coli, S. aureus and C. albicans.
    • 本公开部分涉及包含富集量的某些具有抗感染活性的化合物的蔓越莓(牛痘macrocarpon)的提取物。 抗菌和/或抗真菌活性,例如 针对白色念珠菌的活性。 本公开的另一方面涉及组合的蔓越莓和肉桂提取物。 在某些实施方案中,这些组合的提取物已被优化以控制由大肠杆菌,金黄色葡萄球菌和白色念珠菌引起的尿路感染。 提取物的某些实施方案富含生物活性化合物,其已被证明可抑制白色念珠菌粘附和/或生物膜形成及其体外生长。 在本公开的另一方面,提取物富含衍生自蔓越莓和肉桂的生物活性物质,其已被证明可抑制普通尿道病原体如大肠杆菌,金黄色葡萄球菌和白色念珠菌的附着和生长。